US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concerns
The oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and organ damage and reduce life expectancy.
यह समाचार India National श्रेणी से संबंधित है। अधिक विवरण के लिए मूल स्रोत देखें।
[स्वचालित सारांश | TID News]